Trevor Bezdek Net Worth, Relationships, Age/Birthdate & Birthday

Navigating Change — The Unconventional Journey of Trevor Bezdek

Entrepreneurs often follow predictable trajectories: a great idea, startup buzz, rapid valuation growth, and then—a public sale or acquisition. But Trevor Bezdek’s path has always carried a distinct unconventional edge. As a co-founder of GoodRx and a serial tech entrepreneur before that, Bezdek carved a career shaped as much by risk and reinvention as by financial success. His story is one of vision, timing, and the quiet resolve to do things differently.

From Tech-Consulting Roots to Disrupting Healthcare Access

Before GoodRx, Bezdek built his foundation in the tech world by founding Tryarc LLC — a technology services firm delivering strategy and implementation work for healthcare and media organizations.  Over time, Tryarc drawn interest from larger players; its eventual acquisition opened the door for Bezdek to step toward broader ambitions. 

He also had earlier ventures, including co-founding another firm, BioWire AB. These ventures helped him build operational experience, understand healthcare and technology markets, and hone a sense for where value could be unlocked.

In 2011, this accumulated experience and entrepreneurial drive culminated in the founding of GoodRx. What began as a platform to help consumers navigate opaque prescription costs soon expanded into a broader healthcare-tech play, combining discounted prescriptions with telemedicine and digital health services. 

The IPO Windfall — Transforming Equity Into Real Wealth

When GoodRx went public in September 2020, it marked a major inflection point. On its first trading day, the company’s shares surged, giving co-CEOs—including Bezdek—a windfall.  According to initial filings, at that moment Bezdek’s stake alone was estimated at roughly $227 million. 

However, calculating net worth based purely on historic stake valuations can be misleading. Recent estimates — based on publicly traded shares and reported holdings — place a more conservative figure. According to one source, Bezdek owns 2.6 million shares of GoodRx and has a publicly reported net worth of about $25.2 million.  Another widely referenced breakdown suggests a net worth of ≈ $21 million, reflecting currently declared holdings. 

Because of this variation, some earlier (and now outdated) outlets have listed far larger figures — even as high as US$2 billion. But those numbers appear rooted in pre-IPO unrealized equity valuations or speculative calculations, making them unreliable by current publicly available data.

Thus, a realistic—and more modest—public-market estimate of Bezdek’s net worth places him in the low tens of millions today, rooted primarily in his GoodRx shareholding and past liquidity events.

Evolution of Role and Recent Moves

For many years, Bezdek served as Co-Chief Executive Officer of GoodRx, alongside Doug Hirsch, sharing executive decisions and shaping the company’s direction.  He was also a director and held board positions.

In a recent development — per public filings — Bezdek stepped down from his role as Co-Chairman of the Board of Directors of one subsidiary of GoodRx, effective November 1, 2025.  Simultaneously, his name surfaced as joining the board of another healthcare-technology company, TailorMed, suggesting a continued interest and influence in health-tech ventures.

This transition underscores a shift from day-to-day operations to more strategic, advisory, and investment-focused leadership — a common evolution for founders seeking to broaden their impact beyond a single enterprise.

Beyond Business: Lifestyle, Philanthropy, and Personal Life

Bezdek’s success allowed for a lifestyle marked by significant real estate investments. In 2021, he and his wife, Jana Bezdek, purchased a Malibu Colony beachfront property — a half-acre estate with multiple buildings, pool, and beachfront access — in an off-market deal worth US$39.6 million.  This was in addition to their earlier acquisitions, indicating a preference for homes blending privacy, luxury, and long-term value.

His non-profit and educational interests also show up on his resume: a seat on the board of trustees for Crossroads School for Arts & Sciences, and membership in Young Presidents' Organization, positioning him among leaders seeking to engage beyond pure business.

Personal details about relationships remain sparse outside public real estate filings; beyond his mention alongside his wife Jana in real estate reports, there is little credible public information about his private life or other relationships, which suggests Bezdek prefers to keep personal matters low-key — a choice quite common among tech founders and entrepreneurs of his generation.

Age, Birthdate and the Privacy Around It

Public records about Bezdek’s personal data show conflicting and incomplete details. Some profiles list an approximate age — for instance, one source gives “47 years” but does not consistently publish a birthdate.

Moreover, no authoritative, reliable source has published a confirmed birthdate (month, day, and year) for Trevor Bezdek. Major outlets covering business executives, such as Bloomberg and corporate filings, omit this data.

Because of this absence, I am unable to provide a verified date of birth or birthday. This privacy — intentional or incidental — mirrors a broader pattern among entrepreneurs who value discretion about their personal lives.

The Legacy in Motion — What Bezdek’s Journey Means for Healthcare and Entrepreneurship

Trevor Bezdek’s path reflects the evolving story of healthcare in the 21st century. He leveraged early tech-consulting experience to build a consumer-facing health-tech platform that disrupted drug-pricing opacity in America. As the healthcare landscape continues to digitize, his pivot from operations to strategic advisory roles suggests a new paradigm: founders who help shape systems rather than just lead companies.

At GoodRx’s IPO, Bezdek — and the company — embodied the promise of democratizing access to affordable medication. That promise, even if the personal net worth figures have normalized, continues to resonate in millions of Americans who rely on platforms like GoodRx to manage healthcare costs.

Whether through board engagements at emerging healthcare startups, smart real-estate positioning, or quiet philanthropy and education involvement, Bezdek’s influence appears to be expanding — beyond the moment of a public offering toward a more diversified, long-term impact.

Why Public Estimates of Net Worth Diverge — And What That Means for Readers

When you read sources claiming that Trevor Bezdek is a “billionaire,” take the figure with caution. High numbers often stem from pre-IPO valuations, theoretical equity worth, or optimistic speculative calculations. For example, while one profile once claimed a net worth of US$2 billion,  more recent, publicly verifiable holdings—SEC disclosures and share-value computations — place his wealth closer to US$21–25 million.

This spread underscores a crucial lesson for anyone analyzing executive wealth: the difference between paper valuation and realized value — and the importance of relying on transparent, up-to-date holdings data rather than historical peaks or speculative brand narratives.